{{expand English}}

'''万灵科制药'''<ref>{{cite web |author1=文景 |title=申请破产！美国又有制药商出大事 |url=https://xw.qq.com/cmsid/20201017A069K800 |website=xw.qq.com |accessdate=2021-01-15 |language=zh-cn |archive-date=2022-03-04 |archive-url=https://web.archive.org/web/20220304072447/https://xw.qq.com/cmsid/20201017A069K800 |dead-url=no }}</ref>（{{lang-en|Mallinckrodt Pharmaceuticals}}）是一家总部设在爱尔兰的美国制药公司，1867年成立，产品有{{tsl|en|Adrenocorticotropic hormone (medication)|肾上腺皮质激素}}、[[仿制药|仿制药]]和[[成像剂|成像剂]]。<ref name="Wall Street Journal">{{cite web | title = Mallinckrodt | url = https://online.wsj.com/article/BT-CO-20130701-703560.html | work = [[The_Wall_Street_Journal|The Wall Street Journal]] | date = 1 July 2013 | subscription = yes | access-date = 2021-01-15 | archive-date = 2013-12-10 | archive-url = https://web.archive.org/web/20131210064932/http://online.wsj.com/article/BT-CO-20130701-703560.html | dead-url = no }}</ref>2017年，该公司90%的营业额来自美国医疗卫生系统。<ref>{{cite web|url=https://www.independent.ie/business/irish/mallinckrodt-agrees-deal-to-exploit-irish-tax-base-30163963.html|title=Mallinckrodt agrees deal to exploit Irish tax base|publisher=[[Irish_Independent|Irish Independent]]|date=8 April 2014|quote=Pharma firm Mallinckrodt has agreed to buy Questcor Pharmaceuticals for $5.6bn (€4bn) to add specialty drugs in the latest industry deal that moves a US company to Ireland for a lower tax rate. Mallinckrodt, with a registered headquarters in Dublin and run from Hazelwood, Missouri, will pay $86.08 a share for Anaheim, California-based Questcor.|access-date=2021-01-15|archive-date=2022-03-04|archive-url=https://web.archive.org/web/20220304074257/https://www.independent.ie/business/irish/mallinckrodt-agrees-deal-to-exploit-irish-tax-base-30163963.html|dead-url=no}}</ref>

== 参考资料 ==
{{reflist}}

[[Category:纽约证券交易所已除牌公司|Category:纽约证券交易所已除牌公司]]
[[Category:爱尔兰制药公司|Category:爱尔兰制药公司]]
[[Category:美國場外交易市場上市公司|Category:美國場外交易市場上市公司]]

{{US-company-stub}}